Peer-reviewed veterinary case report
Leuprolide treatment reduces hormone signs in ferrets with adrenal
By Wagner, R A et al.·Published in Journal of the American Veterinary Medical Association·2001·Department of Laboratory Animal Resources, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Leuprolide acetate treatment of adrenocortical disease in ferrets.
- Species:
- rodent
Plain-English summary
A group of 20 ferrets with adrenocortical disease, which can cause symptoms like vulvar swelling, itching, and aggressive behavior, were treated with a medication called leuprolide acetate. After just two weeks, many of the ferrets showed improvements, including reduced swelling and hair regrowth by four weeks. However, the benefits of the treatment were temporary, with symptoms returning within about 3.7 months on average. While leuprolide helped alleviate the symptoms, the long-term safety of this treatment in ferrets is still unclear.
People also search for: ferret adrenocortical disease treatment · leuprolide acetate for ferrets · ferret itching and aggression · ferret hormone treatment
Abstract
OBJECTIVE: To determine the effects of leuprolide acetate, a long-acting gonadotropin-releasing hormone analog, in ferrets with adrenocortical diseases. DESIGN: Case series. ANIMALS: 20 ferrets with adrenocortical disease diagnosed on the basis of clinical signs and plasma sex hormone concentrations. PROCEDURE: Ferrets were treated with leuprolide (100 microg, IM, once), and plasma hormone concentrations were measured before and 3 to 6 weeks after treatment. RESULTS: Leuprolide treatment resulted in significant reductions in plasma estradiol, 17 alpha-hydroxyprogesterone, androstenedione, and dehydroepiandrosterone concentrations and eliminated or reduced clinical signs associated with adrenocortical disease. Decreases in vulvar swelling, pruritus, and undesirable sexual behaviors and aggression were evident 14 days after treatment; hair regrowth was evident by 4 weeks after treatment. The response to treatment was transitory, and clinical signs recurred in all ferrets. Mean +/- SEM time to recurrence was 3.7 +/- 0.4 months (range, 1.5 to 8 months). CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that leuprolide can be safely used to temporarily eliminate clinical signs and reduce sex hormone concentrations in ferrets with adrenocortical diseases. However, the safety of long-term leuprolide use in ferrets has not been investigated, and the long-term effects of leuprolide in ferrets with nodular adrenal gland hyperplasia or adrenal gland tumors are unknown.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/11330611/